|
1
|
Wishart TM, Parson SH and Gillingwater TH:
Synaptic vulnerability in neurodegenerative disease. J Neuropathol
Exp Neurol. 65:733–739. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Whiteley W, Tseng MC and Sandercock P:
Blood biomarkers in the diagnosis of ischemic stroke: A systematic
review. Stroke. 39:2902–2909. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kam PC, Kavanagh R and Yoong FF: The
arterial tourniquet: Pathophysiological consequences and
anaesthetic implications. Anaesthesia. 56:534–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McEwen JA: Complications of and
improvements in pneumatic tourniquets used in surgery. Med Instrum.
15:253–257. 1981.PubMed/NCBI
|
|
5
|
Rorabeck CH: Tourniquet-induced nerve
ischemia: An experimental investigation. J Trauma. 20:280–286.
1980. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bickler PE and Donohoe PH: Adaptive
responses of vertebrate neurons to hypoxia. J Exp Biol.
205:3579–3586. 2002.PubMed/NCBI
|
|
7
|
Nishimura M: Factors influencing an
increase in spontaneous transmitter release by hypoxia at the mouse
neuromuscular junction. J Physiol. 372:303–313. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bukharaeva EA, Salakhutdinov RI, Vyskocil
F and Nikolsky EE: Spontaneous quantal and non-quantal release of
acetylcholine at mouse endplate during onset of hypoxia. Physiol
Res. 54:251–255. 2005.PubMed/NCBI
|
|
9
|
David G, Nguyen K and Barrett EF: Early
vulnerability to ischemia/reperfusion injury in motor terminals
innervating fast muscles of SOD1-G93A mice. Exp Neurol.
204:411–420. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hatzipantelis KP, Natsis K and Albani M:
Effect of acute limb ischaemia on neuromuscular function in rats.
Eur J Surg. 167:831–838. 2001. View Article : Google Scholar
|
|
11
|
Northington FJ, Ferriero DM, Flock DL and
Martin LJ: Delayed neurodegeneration in neonatal rat thalamus after
hypoxia-ischemia is apoptosis. J Neurosci. 21:1931–1938.
2001.PubMed/NCBI
|
|
12
|
Graham SH and Chen J: Programmed cell
death in cerebral ischemia. J Cereb Blood Flow Metab. 21:99–109.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Linnik MD, Zobrist RH and Hatfield MD:
Evidence supporting a role for programmed cell death in focal
cerebral ischemia in rats. Stroke. 24:2002–2008; discussion
2008–2009. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ferrer I and Planas AM: Signaling of cell
death and cell survival following focal cerebral ischemia: Life and
death struggle in the penumbra. J Neuropathol Exp Neurol.
62:329–339. 2003.PubMed/NCBI
|
|
15
|
Kato H and Kogure K: Biochemical and
molecular characteristics of the brain with developing cerebral
infarction. Cell Mol Neurobiol. 19:93–108. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Newcomb JD, Ajmo CJ, Sanberg CD, Sanberg
PR, Pennypacker KR and Willing AE: Timing of cord blood treatment
after experimental stroke determines therapeutic efficacy. Cell
Transplant. 15:213–223. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cummins EP and Taylor CT:
Hypoxia-responsive transcription factors. Pflugers Arch.
450:363–371. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Licausi F, Weits DA, Pant BD, Scheible WR,
Geigenberger P and van Dongen JT: Hypoxia responsive gene
expression is mediated by various subsets of transcription factors
and miRNAs that are determined by the actual oxygen availability.
New Phytol. 190:442–456. 2011. View Article : Google Scholar
|
|
19
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang GL, Jiang BH, Rue EA and Semenza GL:
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS
heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci
USA. 92:5510–5514. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pouyssegur J, Dayan F and Mazure NM:
Hypoxia signalling in cancer and approaches to enforce tumour
regression. Nature. 441:437–443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kaelin WJ and Ratcliffe PJ: Oxygen sensing
by metazoans: The central role of the HIF hydroxylase pathway. Mol
Cell. 30:393–402. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Piret JP, Mottet D, Raes M and Michiels C:
Is HIF-1alpha a pro- or an anti-apoptotic protein? Biochem
Pharmacol. 64:889–892. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Akakura N, Kobayashi M, Horiuchi I, Suzuki
A, Wang J, Chen J, Niizeki H, Kawamura KI, Hosokawa M and Asaka M:
Constitutive expression of hypoxia-inducible factor-1alpha renders
pancreatic cancer cells resistant to apoptosis induced by hypoxia
and nutrient deprivation. Cancer Res. 61:6548–6554. 2001.PubMed/NCBI
|
|
25
|
Zhang B, Yin CP, Zhao Q and Yue SW:
Upregulation of hif-1α by hypoxia protect neuroblastoma cells from
apoptosis by promoting survivin expression. Asian Pac J Cancer
Prev. 15:8251–8257. 2014. View Article : Google Scholar
|
|
26
|
Chen D, Li M, Luo J and Gu W: Direct
interactions between HIF-1 alpha and Mdm2 modulate p53 function. J
Biol Chem. 278:13595–13598. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kothari S, Cizeau J, McMillan-Ward E,
Israels SJ, Bailes M, Ens K, Kirshenbaum LA and Gibson SB: BNIP3
plays a role in hypoxic cell death in human epithelial cells that
is inhibited by growth factors EGF and IGF. Oncogene. 22:4734–4744.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
29
|
Bailly K, Ridley AJ, Hall SM and Haworth
SG: RhoA activation by hypoxia in pulmonary arterial smooth muscle
cells is age and site specific. Circ Res. 94:1383–1391. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nicholson DW and Thornberry NA: Apoptosis.
Life and death decisions. Science. 299:214–215. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dada LA, Novoa E, Lecuona E, Sun H and
Sznajder JI: Role of the small GTPase RhoA in the hypoxia-induced
decrease of plasma membrane Na, K-ATPase in A549 cells. J Cell Sci.
120:2214–2222. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Desbuards N, Antier D, Rochefort GY,
Apfeldorfer CS, Schenck E, Hanton G and Hyvelin JM: Dexfenfluramine
discontinuous treatment does not worsen hypoxia-induced pulmonary
vascular remodeling but activates RhoA/ROCK pathway: Consequences
on pulmonary hypertension. Eur J Pharmacol. 602:355–363. 2009.
View Article : Google Scholar
|
|
33
|
Semenza GL: HIF-1 and human disease: One
highly involved factor. Genes Dev. 14:1983–1991. 2000.PubMed/NCBI
|
|
34
|
Wang GL and Semenza GL: Purification and
characterization of hypoxia-inducible factor 1. J Biol Chem.
270:1230–1237. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li C and Jackson RM: Reactive species
mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol
Cell Physiol. 282:C227–C241. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chandel NS and Schumacker PT: Cellular
oxygen sensing by mitochondria: Old questions, new insight. J Appl
Physiol (1985). 88:1880–1889. 2000.
|
|
37
|
Chandel NS, Maltepe E, Goldwasser E,
Mathieu CE, Simon MC and Schumacker PT: Mitochondrial reactive
oxygen species trigger hypoxia-induced transcription. Proc Natl
Acad Sci USA. 95:11715–11720. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pearlstein DP, Ali MH, Mungai PT, Hynes
KL, Gewertz BL and Schumacker PT: Role of mitochondrial oxidant
generation in endothelial cell responses to hypoxia. Arterioscler
Thromb Vasc Biol. 22:566–573. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vega FM and Ridley AJ: Rho GTPases in
cancer cell biology. FEBS Lett. 582:2093–2101. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Boureux A, Vignal E, Faure S and Fort P:
Evolution of the Rho family of ras-like GTPases in eukaryotes. Mol
Biol Evol. 24:203–216. 2007. View Article : Google Scholar
|
|
41
|
Jaffe AB and Hall A: Rho GTPases:
Biochemistry and biology. Annu Rev Cell Dev Biol. 21:247–269. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bishop AL and Hall A: Rho GTPases and
their effector proteins. Biochem J. 48(Pt 2): 241–255. 2000.
View Article : Google Scholar
|
|
43
|
Wilkins A and Insall RH: Small GTPases in
Dictyostelium: Lessons from a social amoeba. Trends Genet.
17:41–48. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gomez del Pulgar T, Benitah SA, Valerón
PF, Espina C and Lacal JC: Rho GTPase expression in tumourigenesis:
Evidence for a significant link. Bioessays. 27:602–613. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gouw LG, Reading NS, Jenson SD, Lim MS and
Elenitoba-Johnson KS: Expression of the Rho-family GTPase gene RHOF
in lymphocyte subsets and malignant lymphomas. Br J Haematol.
129:531–533. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Benitah SA, Valerón PF, van Aelst L,
Marshall CJ and Lacal JC: Rho GTPases in human cancer: An
unresolved link to upstream and downstream transcriptional
regulation. Biochim Biophys Acta. 1705:121–132. 2004.PubMed/NCBI
|
|
47
|
Merajver SD and Usmani SZ: Multifaceted
role of Rho proteins in angiogenesis. J Mammary Gland Biol
Neoplasia. 10:291–298. 2005. View Article : Google Scholar
|
|
48
|
Wong WW, Dimitroulakos J, Minden MD and
Penn LZ: HMG-CoA reductase inhibitors and the malignant cell: The
statin family of drugs as triggers of tumor-specific apoptosis.
Leukemia. 16:508–519. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Graaf MR, Richel DJ, van Noorden CJ and
Guchelaar HJ: Effects of statins and farnesyltransferase inhibitors
on the development and progression of cancer. Cancer Treat Rev.
30:609–641. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Denoyelle C, Vasse M, Korner M, Mishal Z,
Ganné F, Vannier JP, Soria J and Soria C: Cerivastatin, an
inhibitor of HMG-CoA reductase, inhibits the signaling pathways
involved in the invasiveness and metastatic properties of highly
invasive breast cancer cell lines: An in vitro study.
Carcinogenesis. 22:1139–1148. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sawada K, Morishige K, Tahara M, Kawagishi
R, Ikebuchi Y, Tasaka K and Murata Y: Alendronate inhibits
lysophosphatidic acid-induced migration of human ovarian cancer
cells by attenuating the activation of rho. Cancer Res.
62:6015–6020. 2002.PubMed/NCBI
|
|
52
|
Kusama T, Mukai M, Tatsuta M, Nakamura H
and Inoue M: Inhibition of transendothelial migration and invasion
of human breast cancer cells by preventing geranylgeranylation of
Rho. Int J Oncol. 29:217–223. 2006.PubMed/NCBI
|
|
53
|
Bijian K, Takano T, Papillon J, Le Berre
L, Michaud JL, Kennedy CR and Cybulsky AV: Actin cytoskeleton
regulates extracellular matrix-dependent survival signals in
glomerular epithelial cells. Am J Physiol Renal Physiol.
289:F1313–F1323. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Gómez J, Martínez C, Giry M, García A and
Rebollo A: Rho prevents apoptosis through Bcl-2 expression:
Implications for interleukin-2 receptor signal transduction. Eur J
Immunol. 27:2793–2799. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Blanco-Colio LM, Villa A, Ortego M,
Hernández-Presa MA, Pascual A, Plaza JJ and Egido J:
3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors,
atorvastatin and simvastatin, induce apoptosis of vascular smooth
muscle cells by downregulation of Bcl-2 expression and Rho A
prenylation. Atherosclerosis. 161:17–26. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Fromigué O, Haÿ E, Modrowski D, Bouvet S,
Jacquel A, Auberger P and Marie PJ: RhoA GTPase inactivation by
statins induces osteosarcoma cell apoptosis by inhibiting
p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell
differentiation. Cell Death Differ. 13:1845–1856. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Li X, Liu L, Tupper JC, Bannerman DD, Winn
RK, Sebti SM, Hamilton AD and Harlan JM: Inhibition of protein
geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis
in human endothelial cells. J Biol Chem. 277:15309–15316. 2002.
View Article : Google Scholar : PubMed/NCBI
|
